$RPRX is waiting for FDA's approval for their drug
Post# of 22756
Posted On: 11/30/2015 10:25:20 PM
$RPRX is waiting for FDA's approval for their drug Enclomiphene. currently there's a drug called Clomiphene its perscribed to women and its a weak estrogen-like hormone that acts on the hypothalamus, pituitary gland, and ovary to increase levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH, which is also important in the process of ovulation).
The Drug $RPRX is waiting approval on will be used for men. It's got a differrent chemical makeup then Clomiphene that targets testosterone and will be perscribed for men based on the studies the results are very good.
The alternative is either shots that need to be taken weekly or pellets that need to be placed surgically under the skin. neither of these will compare!
since Enclomiphene is essentially Clomiphene but formulated differently to target low testosterone. I don't see how the FDA would not approve it I've also heard that Clomiphene in it's current state has also been perscribed to Men with no major side effects. Also as a kicker $RPRX believes that it can also be formulated to fight Low T associated with type II diabetes.
It's estimated that Low T affects roughly 13 million Men in the US alone.
$RPRX will submit for European approval in the first quarter of 2016.
The company also believes that Hypogonadism low T is reversable while taking their drug as appose to just taking testosterone shots for life.
The Drug $RPRX is waiting approval on will be used for men. It's got a differrent chemical makeup then Clomiphene that targets testosterone and will be perscribed for men based on the studies the results are very good.
The alternative is either shots that need to be taken weekly or pellets that need to be placed surgically under the skin. neither of these will compare!
since Enclomiphene is essentially Clomiphene but formulated differently to target low testosterone. I don't see how the FDA would not approve it I've also heard that Clomiphene in it's current state has also been perscribed to Men with no major side effects. Also as a kicker $RPRX believes that it can also be formulated to fight Low T associated with type II diabetes.
It's estimated that Low T affects roughly 13 million Men in the US alone.
$RPRX will submit for European approval in the first quarter of 2016.
The company also believes that Hypogonadism low T is reversable while taking their drug as appose to just taking testosterone shots for life.
(0)
(0)Scroll down for more posts ▼